Abdelrahman H. Daifalla: Is the Couple Clinically Ready to Proceed with IVF or ICSI?
Abdelrahman H. Daifalla, Medical Director and Consultant in IVF/ICSI at Queens Medical Center and Consultant in IVF and Reproductive Medicine at Gannah IVF Hospital, shared on LinkedIn:
“Before IVF or ICSI begins, there is a fundamental question that is not always easy to answer:
Is this couple clinically ready to proceed – or is there something actionable to optimize first, and why?
Today, I am sharing the first public, non-confidential clinical demonstration of DISS – Daifalla IVF Success System.
DISS is a clinician-led Clinical Intelligence Framework being developed to organize fragmented fertility information into an explainable, structured, and physician-supervised readiness pathway.
Using a completely synthetic couple – not real patients – this demonstration shows how DISS may support the clinical team through:
- Structured capture of the couple’s fertility journey
- Detection of missing, incomplete, or outdated evidence
- Identification of unresolved clinical and safety gates
- Mapping across five clinical pillars
- Stage-specific readiness for stimulation, oocyte retrieval and embryo transfer
- A prioritized physician-supervised management roadmap
- Guideline-informed protocol decision support
- An Expert Opinion Layer allowing a senior clinician to Accept, Amend, Defer or Escalate the proposed output
- A preserved audit trail connecting each finding to its action, evidence and final clinical decision
The most important principle is simple:
DISS does not replace the fertility physician.
It is designed to help organize clinical reasoning, expose missing evidence, connect findings across disciplines and present guideline-supported options – while final authority remains entirely with the treating physician and the institution.
DISS remains development-stage and validation-first.
I am not asking institutions to assume that it works.
I am inviting universities, fertility centres, hospital groups, reproductive-medicine researchers, responsible-AI teams and fertility-technology organizations to help test:
- Where DISS adds measurable clinical decision value
- Where it does not
- How reproducible its outputs are
- Whether it improves missing-data detection and review consistency
- How it performs in retrospective evaluation and prospective silent mode
- What governance is required before any clinical deployment
I would be pleased to explore independent scientific review, multicentre validation, clinical-workflow assessment, responsible-AI collaboration, and governed pilot studies.
Your scientific and clinical feedback would be deeply valued.”

Other articles featuring Abdelrahman H. Daifalla on Fertility News.
-
Nov 18, 2026, 18:26Ritu Anand: We’ve Been Talking about Her Fertility – It’s Time to Talk about His
-
Nov 18, 2026, 18:20Sean Lauber: Is It Safe to Thaw and Rebiopsy an Embryo?
-
Nov 18, 2026, 18:14Arsiak Vartenian: 8 Years of Answering “Do You Have Kids?” Is a Long Time
-
Nov 18, 2026, 18:09Esther Eleboh: When the Same Protocol Produces Completely Different Embryo Outcomes
-
Nov 18, 2026, 18:05Resa Nabor: Having PCOS Doesn’t Make You Less of a Woman or Less Deserving of Love
-
Nov 18, 2026, 17:47Diana Kayal: Co-Chairing the 3rd International Conference on Gynecology and Women’s Health
-
Nov 18, 2026, 17:44Karthik Raj: Oocyte Quality Is Not Determined at Retrieval Alone
-
Nov 18, 2026, 17:41Tazeen Farhan: 10 Small Lifestyle Changes to Support Reproductive Health
-
Nov 18, 2026, 17:35Chanju Jung: Nature Paper Explores Base Editing in Human Embryos
